Results of Combined Cataract and Glaucoma Surgery with Mitomycin C.
- Author:
Dong Yeon LEE
1
;
Dong Min KIM
;
Myung Hee KIM
;
Chung Sook AHN
Author Information
1. Department of Ophthalmology, College of Medicine, Ewha Womans University, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Cataract;
Combined procedure;
Glaucoma;
Mitomycin C
- MeSH:
Cataract*;
Fibrin;
Follow-Up Studies;
Glaucoma*;
Humans;
Hyphema;
Intraocular Pressure;
Macular Edema;
Mitomycin*;
Postoperative Complications;
Retrospective Studies;
Uveitis;
Visual Acuity;
Wounds and Injuries
- From:Journal of the Korean Ophthalmological Society
1996;37(11):1884-1892
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
To evaluate the results for intraocular pressure (IOP), visual acuity and postoperative complications, we conducted a retrospective review of the records of 29 consecutive cases who had combined cataract and glaucoma surgery with mitomycin C (0.2mg/ml) in patients with coexisting cataract and glaucoma. The mean follow-up period was 6.8 +/- 1.8 months. The mean preoperative lOP was 26.3 +/- 9.1mmHg(range, 11-44mmHg), which decreased by mean 12.1mmHg to a mean postoperative IOP of 14.2 +/- 3.4mmHg(range,7-22mmHg) as measured at the last follow-up. At the last follow-up, 21 eyes(72.4%) had IOPs of 21mmHg or less without glaucoma medications as complete sucess. The mean preoperative number of antiglaucoma medication was 2.4 +/- 1.0 (range, 1-4), which decrease to a mean number of antiglaucoma medication of 0.4 +/- 0.7 (range, 0-2) at the last follow-up. All patients were using fewer medications at last follow-up than preoperatively. Twenty two eyes (75.9%) had a best-corrected visual acuity of 0.5 or better at the last follow-up. Last follow-up best-corrected visual acuity was better than the preoperative best-corrected visual acuity for all patients. Six eyes (20.7%) had fibrinous uveitis as the most common postoperative complication, and other complications were hyphema, wound leak and cystoid macular edema etc. The glaucoma triple procedure with adjunctive mitomycin C(0.2mg/ml) appears to be a safe and effective surgical technique for treating patients with coexisting cataract and glaucoma.
